Welcome to the General Thoracic Surgery Program website. Our goal is to provide compassionate, state-of-the-art care to patients with diseases of the chest and surrounding organs including lung cancer, mesothelioma and esophageal cancer.
Patients diagnosed with lung cancer must often shoulder not only the burden of the disease, but the stigma that they somehow "brought it on themselves" by smoking. Even patients who have never smoked are harmed by these attitudes because historically it has dampened research funding. I strongly reject this "blame the victim" mentality as do my fellow thoracic surgeons in this program. At UCSF, our surgeons treat patients diagnosed with lung cancer with compassion and empathy, and understand only too well that smoking is an addiction and should be treated like any other disease. Our sole focus is on treatment and hope.
We are proud to be a regional, national, and international referral center for lung cancer. The UCSF program is known for its state-of-the-art care and our surgeons' willingness to be aggressive in the appropriate case. We are a high volume center for thoracic surgery and our peri-operative mortality rates are among the lowest anywhere.
Our surgeons are highly trained in performing minimally invasive thoracic surgery for lung cancer and other thoracic malignancies. Close to one-third of our lung cancer surgeries are now carried out using video-assisted thoracic surgery or VATS. This minimally invasive technique means shorter hospital stays, less post-operative pain, and a more rapid return to normal activities. For patients who need chemotherapy after surgery, so-called adjuvant therapy, it often means they can start their treatment sooner and are better able to tolerate higher doses of chemo.
Our thoracic surgeons work closely with UCSF faculty including specialists in the departments of Medicine, Pathology and Radiation Oncology. These doctors add the multidisciplinary expertise needed for treating patients both before and after surgery.
Our basic scientists also have a strong commitment to treating and curing lung cancer and our clinical investigators are committed to offering clinical trials for each and every stage of the diseases we treat.
Thank you for visiting our site.
David M. Jablons, M.D.
Professor of Surgery
Chief, Section of General Thoracic Surgery
Ada Distinguished Professor and Program Leader of Thoracic Oncology
University of California, San Francisco